Said it failed to state ethical aspects involved in the study Proposal was based on the assumption that vaccine was safe and efficacious: PHFI Brinda demands compensation for all subjects victimised by vaccine programme The proposal for conducting the now controversial “Post-licensure observational study of Human Papilloma Virus (HPV) vaccination: Demonstration Project,” carried out by a non-governmental organisation PATH for two major pharmaceutical companies, had been turned down by the Public Health Foundation...

Rules out blanket ban on or approval of such studies ‘HPV vaccination should supplement cervical cancer screening programme' The three-member committee, set up to probe the alleged irregularities in conducting studies using human papillomavirus (HPV) vaccine by PATH in India, has identified several deficiencies in the planning and implementation of the project leading “to a crisis requiring suspension of the study,” but has fallen short of fixing responsibility on any individual or...

Adjuvants with severe physiological side effect have been administered to hundreds of children during vaccine trials conducted at a government hospital in Indore over the last few years, and that too without the approved Standard Operating Procedure (SOP). The trials conducted on at least 836 children at the Chacha Nehru Bal Chikitsalaya, the paediatric division of the Maharaja Yashwantrao Hospital, were spiked with adjuvants that contain high levels of mercury, aluminium,...

‘Trade secret of third party' can't be disclosed: Drugs-Controller Application seeks information on the basis of approval for import and marketing of vaccines It seeks to know protocols for permission to an NGO and ICMR to conduct ‘demonstration project' Information on the demonstration project and licensing of two vaccines to prevent cervical cancer has been exempted from public disclosure under Section 8 of the Right to Information Act, 2005. This is the reply received...

The health ministry on Thursday forcefully denied the allegation levelled by the opposition that Indian girls are being used as guinea pigs for anti-cervical cancer vaccines. Health minister Ghulam Nabi Azad, replying to a calling attention notice in the Rajya Sabha, said that use of HPV (human papillomavirus) vaccines imported by Merck and CERVARIX (manufactured by GSK) have been stopped in the country. The ministry has also constituted a committee...